Stay updated on AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.

Latest updates to the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment has closed. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), alongside a minor header formatting change (Intervention/Treatment) and a page revision tag (Revision: v3.6.0).SummaryDifference0.4%

- Check16 days agoChange DetectedThe page's revision label updated from v3.5.4 to v3.5.5, indicating a newer version of the page content. This is a metadata update rather than a substantive change to the information presented.SummaryDifference0.0%

- Check38 days agoChange DetectedA new revision label v3.5.4 appears on the page, replacing the previous v3.5.3 and signaling a newer page build. The update does not modify the study details or other visible content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check96 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.